Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“What a wonderful start to the Milken Institute Health Summit, solving for increasing access to clinical trials through technology with fellow speakers Kent Thoelke, John Halamka and Sir Martin Landray.
This is a group that gets things done!
Looking forward to doing more together, on behalf of cancer patients and their families.”
More posts featuring Karen Knudsen on OncoDaily.